Shares of Septerna, Inc. (SEPN) Monday announced the appointment of Gil Labrucherie as chief financial officer. Shares are dropping about 8% in the pre-market.
Labrucherie carries 25 years of experience and is a seasoned biopharma executive skilled in senior leadership experience in finance and legal roles for public biopharmaceutical and technology companies.
Labrucherie had served as CFO and Chief Business Officer at Acelyrin, Inc.
In the pre-market trading, SEPN is 7.09% less at $22.01 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.